Bioter S.A. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was EUR 0.246 million compared to EUR 0.228 million a year ago. Net loss was EUR 8.81 million compared to net income of EUR 6.05 million a year ago. Basic loss per share from continuing operations was EUR 0.526 compared to basic earnings per share from continuing operations of EUR 0.362 a year ago. Diluted loss per share from continuing operations was EUR 0.5264 compared to diluted earnings per share from continuing operations of EUR 0.3618 a year ago.